Latest Headlines

  1. FDA Approves Cobas Babesia, Roche’s First Whole Blood Test For Donor Screening

    Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for the cobas Babesia test for use on the cobas 6800/8800 Systems for individual blood donation testing

  2. PPD Expanding Bioanalytical Laboratory Capabilities

    Pharmaceutical Product Development, LLC (PPD), is expanding its bioanalytical laboratory in Richmond, Virginia, enhancing its ability to provide industry-leading capabilities to meet biopharmaceutical clients’ increasing research needs

  3. Microbix Quality Products Enter U.S. Market

    Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, is pleased to announce U.S. availability of four innovative in-vitro diagnostic (IVD) control products for evaluating performance, procedures, and workflow of laboratory tests that detect and type HPV nucleic acids (DNA or RNA) in various human tissue samples

  4. Sustainable Solutions For Laboratory Heating And Cooling

    The DrySyn range of heating & cooling blocks from Asynt is enabling laboratories around the world to undertake clean, safe synthetic reactions both individually or in parallel

  5. ViVitro Labs Acquires ProtomedLabs

    ViVitro Labs, the industry-leading provider of cardiovascular device test equipment and related consulting services, announces the acquisition of ProtomedLabs SASU, an ISO 17025 accredited medical device testing laboratory based in Marseille France

  6. LexaGene Develops Test For Deadly Mosquito-Borne EEE Virus

    LexaGene Holdings Inc. (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers that can rapidly detect pathogens and other molecular markers, announced today the development of a test for detection of the deadly, Eastern Equine Encephalitis (EEE) virus on its LX technology platform

  7. Canon Medical Offers Comprehensive Lung Cancer Screening Solution For Early Detection In High-Risk Patients

    Lung cancer is the most common cancer worldwide, accounting for 2.1 million new cases and 1.8 million deaths in 2018

  8. Source Bioscience Invest €585,000 In Stability Storage With New State-Of-The-Art Microbiology And Sterility Testing Labs

    Source Bioscience, an international provider of integrated laboratory services and products, recently announced it has invested €585,000 in microbiology and sterility testing labs at its stability storage facility in Tramore, Co Waterford, Ireland

  9. Sysmex America Joins Clinical Lab 2.0 Movement To Support Collaboration Around Value-Based Healthcare

    Sysmex America, Inc., a leading diagnostic solutions company offering hematology, urinalysis, information systems and flow cytometry testing technology for optimal clinical laboratory performance, has joined the Clinical Lab 2.0 movement to support collaboration around value-based healthcare

  10. Experimental 'Blood Test' Accurately Screens For PTSD

    An artificial intelligence tool – which analyzed 28 physical and molecular measures, all but one from blood samples – confirmed with 77 percent accuracy a diagnosis of posttraumatic stress disorder (PTSD) in male combat veterans, according to a new study